Full-Time

Senior – QC Analyst

Confirmed live in the last 24 hours

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

CA$80k - CA$100kAnnually

+ Equity + Annual Bonus

Senior

Vancouver, BC, Canada

Category
Lab & Research
Medical Research
Requirements
  • You have bachelor’s or master’s degree in an applicable science and 5+ years of relevant QC experience
  • You have a strong knowledge and experience in Good Manufacturing Practices (GMPs), QC analytical and bioanalytical testing and method qualification requirements
  • You have experience with using HPLC, UPLC, capillary electrophoresis, imaged capillary isoelectric focusing, microtiter plate reader spectrophotometer instrumentation and software; microbiology background highly desirable
  • You have excellent interpersonal skills, ability to work independently and in a team environment, detail oriented and organized and methodical in execution of tasks
  • You have an ability to problem solve with sound analytical thinking
Responsibilities
  • Performing sample and routine testing in accordance with approved testing methods of raw materials, in-process materials, packaging materials, and finished products while supporting environmental monitoring for cleanroom facility
  • Contributing to method qualification/transfer activities such as writing working instructions, operational SOPs, test methods, protocols, executing and drafting the report for method qualifications/transfers
  • Performing all routine and stability testing in the analytical laboratory including UPLC, CE-SDS, icIEF, SEC and other separation and compendial techniques in accordance with FDA, USP, ICH and internal SOPs
  • Drafting the reports for out-of-specification (OOS) and/or out-of-trend (OOT) results during release and stability testing in close collaboration with internal teams and/or external testing labs
  • Complying with Good Manufacturing Practices (GMP) and maintaining strict and accurate quality control documentation of all test procedures and results
  • Supporting all activities directly related to the start-up and operational readiness of the GMP QC labs including facilities, calibration of equipment, methods and procedures, and sample and data flows
  • Supporting execution and review of instrument qualification/requalification and Computerized System Validation

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?